Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
Open Access
- 1 April 2026
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (5) , 101561
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Development Fund
- National Natural Science Foundation of China (22277125)
- National Natural Science Foundation of China (92253306)
- National Natural Science Foundation of China (U25A20594)
- National Natural Science Foundation of China (82521004)
- Natural Science Foundation of Shandong Province (ZR2024MB112)
- Key Technology Research and Development Program of Shandong Province (2024CXPT028)
- National Science and Technology Major Project (2023ZD0507800)
- University of the Chinese Academy of Sciences
- Science and Technology Commission of Shanghai Municipality
- Natural Science Foundation of Shanghai Municipality (SYS202205)
- Natural Science Foundation of Shanghai Municipality (23ZR1474600)
- Chinese Academy of Sciences (XDB1060000)
This publication has 50 references indexed in Scilit:
- Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastomaCell Metabolism, 2024
- PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA endsCell, 2024
- Metabolic regulation of homologous recombination repair by MRE11 lactylationCell, 2023
- Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cellsiScience, 2023
- Multifaceted Role of PARP1 in Maintaining Genome Stability Through Its Binding to Alternative DNA StructuresJournal of Molecular Biology, 2023
- Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosisCell Metabolism, 2023
- HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancerLife Sciences, 2022
- The expanding universe of PARP1-mediated molecular and therapeutic mechanismsMolecular Cell, 2022
- Translational control through ribosome heterogeneity and functional specializationTrends in Biochemical Sciences, 2022
- PARP-1 and its associated nucleases in DNA damage responseDNA Repair, 2019